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Objective: To assess glucose and triglyceride excursions 2 hours after the ingestion of a standardized meal and
their associations with clinical characteristics and cardiovascular complications in individuals with diabetes.
Research design and methods: Blood samples of 898 subjects with diabetes were collected at fasting and
2 hours after a meal containing 455 kcal, 14 g of saturated fat and 47 g of carbohydrates. Self-reported morbidity,
socio-demographic characteristics and clinical measures were obtained by interview and exams performed at the
baseline visit of the ELSA-Brasil cohort study.
Results: Median (interquartile range, IQR) for fasting glucose was 150.5 (123–198) mg/dL and for fasting triglycerides 140
(103–199) mg/dL. The median excursion for glucose was 45 (15–76) mg/dL and for triglycerides 26 (11–45) mg/dL. In
multiple linear regression, a greater glucose excursion was associated with higher glycated hemoglobin (10.7, 95% CI
9.1–12.3 mg/dL), duration of diabetes (4.5; 2.6–6.4 mg/dL, per 5 year increase), insulin use (44.4; 31.7–57.1 mg/dL), and
age (6.1; 2.5–9.6 mg/dL, per 10 year increase); and with lower body mass index (−5.6; −8.4– -2.8 mg/dL, per 5 kg/m2
increase). In adjusted logistic regression models, a greater glucose excursion was marginally associated with the presence
of cardiovascular comorbidities (coronary heart disease, myocardial infarction and angina) in those with obesity.
Conclusions: A greater postprandial glycemic response to a small meal was positively associated with indicators of a
decreased capacity for insulin secretion and negatively associated with obesity. No pattern of response was observed
with a greater postprandial triglyceride excursion.Introduction
Diabetes prevalence is increasing worldwide, mainly due
to the aging of the population and the epidemic rise in
obesity [1], the two main determinants of type 2 diabetes.
Diets containing high levels of animal fat and a high gly-
cemic index are associated with both diabetes mellitus
(DM) and cardiovascular disease (CVD), a major compli-
cation of diabetes [2-4]. Hyperglycemia is a major risk
factor for the development of chronic microvascular (ret-
inopathy and nephropathy) and macrovascular (ischemic* Correspondence: barbara.riboldi@gmail.com
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complications [5]. Postprandial hyperglycemia contributes
importantly to overall hyperglycemia and cardiovascular
complications [6].
A 2 h post-load plasma glucose during a 75-g OGTT
is more predictive of overall mortality than fasting glu-
cose [7]. Postprandial hyperglycemia, measured after
breakfast, lunch and dinner, is an independent risk factor
for CVD [8] and mortality [9] among individuals with
diabetes. Additionally, postprandial hypertriglyceridemia
has been shown to be a risk factor for CVD among indi-
viduals without diabetes [10] and is associated with an
increased intima-media thickness of the carotid artery in
individuals with diabetes [11]. However, few large studies
have evaluated glucose and triglyceride post-meal excur-
sions in individuals with diabetes, and their association
with diabetes comorbidities.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cursions 2 hours after the ingestion of a standardized
meal and their associations with clinical characteristics
and the presence of cardiovascular complications in in-
dividuals with diabetes.
Research design and methods
This is a cross-sectional analysis of 2008–2010 baseline
data from the Brazilian Longitudinal Study of Adult
Health (ELSA-Brasil), a multicenter cohort study of
15,105 public sector employees (active or retired) in six
cities in three different regions of Brazil [12]. Of these,
1496 reported a previous diagnosis of diabetes, and 958
(64%) performed the meal test. We excluded 46 partici-
pants because of incomplete meal ingestion or missing
values for fasting or post-meal plasma glucose and tri-
glycerides, and 14 participants reporting diabetes onset
before the age of 40 with insulin being their first medica-
tion, characteristics suggesting type I diabetes. Thus, the
final analysis was performed on 898 diabetic subjects.
ELSA-Brasil was approved by the respective Ethics and
Research Committee of each participating institution,
and participants gave written consent prior to entering
the study.
Sociodemographic data, a past medical history of dia-
betes and other diseases, and drug use were obtained
through a standardized interview. Anthropometric data –
height, weight, waist and hip circumferences and blood
pressure – were measured, blood pressure being obtained
three times with the mean of the last two measurements
used in analyses.
A 12 hour fasting blood sample was drawn by
venipuncture in the morning period following stan-
dardized procedures for samples collection and pro-
cessing [13]. Participants were instructed not to use
medicines on the morning of examinations until after this
collection. The standardized meal was administered
shortly thereafter, and an additional sample was drawn
2 hours later. The meal consisted of four slices (30 grams)
of industrialized toast (Bauducco®), four cubes (20 grams)
of processed cheese (Polenghinho®), and a box (200 ml) of
an orange-flavored drink (Kapo®), totaling, according to la-
bels, 454.8 kcal, and containing 24.4 grams of lipids (13.8
grams of saturated fat), 46.8 grams of carbohydrates, 12.0
grams of protein, and 570 mg of sodium.
Blood specimens were processed locally and then sent
to the central ELSA-Brasil laboratory for analysis. Glucose
was determined by the hexokinase enzymatic method.
Total cholesterol, triglycerides, HDL-cholesterol and LDL-
cholesterol were estimated by the enzymatic colorimetric
method. Insulin was determined by chemiluminescence
(sandwich immunoassay) and C-reactive protein by an au-
tomated immunochemical method [14]. Glucose and tri-
glyceride post-load excursions were defined as thedifference between the corresponding 2 h post-load and
fasting values.
Raised blood pressure was defined as systolic blood pres-
sure ≥ 130 mmHg, a diastolic blood pressure ≥ 85 mmHg
[15], or confirmed use of antihypertensive medication [16];
postural hypotension as a decrease of ≥ 20 mmHg for sys-
tolic or ≥ 10 mmHg for diastolic blood pressure when
changing from supine to standing position [17]. Coronary
disease was defined as a history of angina, myocardial in-
farction, angioplasty or bypass surgery; any cardiovascular
complication as coronary disease, heart failure, or stroke.
Abdominal obesity was considered present when waist cir-
cumference was > 102 cm for men and > 88 cm for women;
hypertriglyceridemia when triglycerides > 150 mg/dL; and
low HDL-cholesterol when HDL-cholesterol was < 40 mg/
dL for men and < 50 mg/dL for women [16]. Continuous
variables were expressed as mean (standard deviation) or
median (interquartile range), according to their distribu-
tion, with Spearman correlation coefficients being used to
assess associations. ANCOVA was used for comparison of
glucose and triglyceride excursions between groups with
different demographic and clinical characteristics.
Linear regression models were constructed to investi-
gate associations of clinical characteristics with glucose
and triglyceride excursions, linearity being assessed
using the Box-Tidwell test. Logistic regression models
were fitted to investigate associations of glucose and tri-
glyceride excursions with the presence of chronic dis-
eases. Multicollinearity among variables was assessed by
the variance inflation factor.
A significance level of 5% was adopted. Analyses were
performed using SAS software (Statistical Analysis Sys-
tem, SAS Institute Inc., Cary, NC), version 9.3.
Results
Table 1 presents clinical and laboratory characteristics of
the 898 participants with diabetes. Of note, median age
was 59.5 (54.0 to 65.0) years, and most were overweight
(42.7%) or obese (41.8%). Median duration of diabetes
was 6 (3.0-12.0) years, and 15.6% were using insulin and
76.6% other medications (principally metformin and sul-
fonylureas) for diabetes. The median for fasting glucose
was 150.5 (123.0 to 198.0) mg/dL and for post-load glu-
cose 200.0 (146.0 to 274.0) mg/dL. The median glucose
excursion was 44.0 mg/dL, with interquartile range from
15.0 to 76.0 mg/dL. The median for fasting plasma
triglycerides was 140 (103.0 to 199.0) mg/dL and for
post-load triglycerides 172.0 (128.0 to 237.0) mg/dL. The
median triglyceride excursion was 26.0 mg/dL, with
interquartile range from 11.0 to 45.0 mg/dL. Only 16.5%
of participants reported a cardiovascular comorbidity.
The strongest correlations with the post-load glucose
excursion were seen with fasting glucose (r = 0.43,
p <0.01), post-load glucose (r = 0.83 p <0.01), and
Table 1 Characteristics of participants with self-reported





Age (years) 59.5 54.0-65.0
Race
Black 220 25.1%
Brown (“pardos”) 230 26.2%
White 383 43.7%




Systolic blood pressure (mmHg) 128.3 117.0-141.5
Diastolic blood pressure (mmHg) 78.0 71.0-85.0
Raised blood pressure 699 78.2%
Duration of diabetes (years) 6 3.0-12.0
Self-referred insulin treatment 131 15.6%
Self-referred oral hypoglycemic treatment
alone
619 76.6%
Self-referred statin treatment 285 31.7%
Self-referred use of other lipid-lowering drugs 33 3.7%
Glycated hemoglobin (%) 6.6 5.8-7.9
Fasting glucose (mg/dL) 150.0 123.0-198.0
2 h post-load glucose (mg/dL) 200.0 146.0-274.0
Glucose excursion (mg/dL)† 44.0 15.0-76.0
Fasting triglycerides (mg/dL) 140.0 103.0-199.0
2 h post-load triglycerides (mg/dL) 172.0 128.0-237.0
Triglyceride excursion (mg/dL)† 26.0 11.0-45.0
Fasting insulin (μU/mL)‡ 8.8 5.1-13.9
Cholesterol (mg/dL) 199.0 173.0-231.0
HDL-cholesterol (mg/dL) 49.0 42.0-59.0
LDL-cholesterol (mg/dL) 116.0 94.0-142.0
Postural hypotension 23 2.6%
Self-reported
Stroke 22 2.5%
Heart failure 43 4.8%
Angina 66 7.4%
Myocardial infarction 51 5.7%
Coronary disease 108 12.0%
Any cardiovascular complication 148 16.5%
ELSA-Brasil, 2008–2010.
Small variations in the total number of individuals are due to missing data.
†2 h post-load level minus fasting level.
‡Only among those not on insulin use (n = 683).
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tions were observed with duration of diabetes (r = 0.34,
p <0.01), waist-hip ratio (r = 0.16, p <0.01), systolic bloodpressure (r = 0.17 p <0.01) and age (r = 0.11, p <0.01).
Correlations for triglyceride excursion were generally
weaker, with no correlation being observed with fasting
triglycerides and a moderate correlation with post-load
triglycerides (r = 0.34, p <0.01). Weak correlations were
present with fasting glucose (r = 0.11, p <0.01), post-load
glucose (r = 0.09, p <0.01), glycated hemoglobin (r = 0.12,
p <0.01) and fasting insulin (r = 0.09, p <0.01), as illus-
trated in Table 2.
In crude analyses (Table 3), the magnitude of the glu-
cose excursions varied with several clinical characteris-
tics. Higher glucose excursions were found among those
with HbA1C values greater than 7%, use of insulin, pos-
tural hypotension, and self-reported cardiovascular co-
morbidity. Lower excursions were found among those
with abdominal obesity and also those receiving only
oral hypoglycemic treatment. No statistically significant
associations were seen with triglyceride excursions.
Table 4 shows analyses of glucose and triglyceride ex-
cursions with adjustment for covariates. In the more ad-
justed analysis, glucose excursion was 7.6 mg/dL greater
in whites, 6.1 mg/dL greater for each 10 years increase
in age; 4.5 mg/dL greater for each five year increase in
duration of diabetes; 10.7 mg/dL greater for each 1% in-
crease of glycated hemoglobin; and 44 mg/dL greater in
the presence of insulin use. Glucose excursion decreased
by 5.6 mg/dL for each 5 kg/m2 increase in body mass
index. For triglyceride excursions, as in the crude ana-
lyses, no variation in magnitude was observed according
to the factors analyzed.
Table 5 presents the associations of glucose and trigly-
ceride excursions with cardiovascular comorbidities,
when adjusted through logistic regression. The results
are presented both globally and with participants strati-
fied into obese and non-obese categories, and odds ra-
tios are expressed for a change of 25 mg/dL in glucose
and triglyceride excursions. Covariate control was lim-
ited given the small number of outcomes observed. In
this regard, only age-adjusted models are presented for
the more specific outcomes (myocardial infarction, an-
gina, stroke, and heart failure). Associations for the total
sample for both glucose and triglyceride excursions were
minimal. However, when the associations were investi-
gated in subgroups, a relatively consistent pattern of
small though generally not statistically significant associ-
ations was frequently seen for obese individuals. With
the exception of stroke, the outcome with fewest cases,
all associations were stronger among the obese, the ex-
cursion – obesity interaction being statistically signifi-
cant for the triglyceride excursion for many of the
outcomes.
In multiply-adjusted analyses in the obese strata, the
presence of any cardiovascular comorbidity was 12% (−8%
to 36%) more frequent for every 25 mg/dL greater glucose
Table 2 Spearman correlation coefficients between clinical and laboratory variables in patients with diabetes during a













Fasting glucose — 0.83** 0.43** 0.26** 0.29** 0.11**
Post-load Glucose 0.83** — 0.83** 0.19** 0.22** 0.09**
Glucose excursion 0.43** 0.83** — 0.05 0.08* 0.04
Fasting triglycerides 0.26** 0.19** 0.05 — 0.94** 0.06
Post-load Triglycerides 0.29** 0.22** 0.08 0.94** — 0.34**
Triglyceride excursion 0.11** 0.09** 0.04 0.06 0.34** —
Glycated hemoglobin 0.73** 0.76** 0.53** 0.15** 0.20** 0.12**
Fasting insulin −0.07* −0.01 0.05 0.20** 0.21** 0.09**
C-reative Protein 0.13** 0.12** 0.06 0.11** 0.11** 0.05
Age −0.08* −0.01 0.11** −0.09* −0.10* −0.05
Body mass index 0.04 −0.01 −0.06 0.20** 0.18** 0.04
Waist circumference 0.11** 0.07* −0.01 0.22** 0.20** 0.01
Waist to hip ratio 0.20** 0.21** 0.16** 0.25** 0.23** −0.01
Duration of Diabetes 0.16** 0.31** 0.34** −0.05 −0.06 −0.06
Systolic blood pressure 0.22** 0.22** 0.17** 0.09** 0.09** 0.02
Diastolic blood pressure 0.24** 0.17** 0.07* 0.11** 0.12** 0.04
ELSA-Brasil, 2008–2010.
†Two-hour post-load level minus fasting level; *P < 0.05; **P < 0.01.
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25 mg/dL greater triglyceride excursion. In this strata, an
increase in the glucose excursion of this magnitude was
associated with a 32% increase in the age-adjusted risk of
having had a myocardial infarction (OR = 1.32, 95% CI
01.03 to 1.68), and an increase in the triglyceride excur-
sion of this magnitude with a 36% increase in the age-
adjusted risk of having a history of angina (OR = 1.36, 95%
CI 1.01 to 1.83).
Discussion
The metabolic response to a test meal of approximately
450 kcal, roughly equivalent to a breakfast meal, led to
2 h glucose and triglyceride values 30% and 20% above
those of fasting. However, the excursions varied widely,
with those in the 75th percentile having an excursion ap-
proximately four times that of those in the 25th percent-
ile for both glucose and triglycerides. Clinical correlates
of a greater glucose excursion suggest that it reflects a
decreased capacity for insulin secretion, whereas no cor-
relates of the triglyceride excursion were identified. In
overall analyses, no associations were found between a
greater excursion and a history of cardiovascular comor-
bidity. However, the relative risk of presenting a comor-
bidity with a larger excursion was generally greater in
the obese, though this risk was never of a large
magnitude.
The major predictors of greater glycemic excursion –
greater age, duration of diabetes, glycated hemoglobinand, especially, the use of insulin – suggest that the main
determinant of the post meal blood glucose excursion
was a relative insulin deficiency. That obesity associated
with a lesser excursion perhaps similarly reflects greater
preservation of the capacity for insulin secretion. Indi-
viduals with a greater excursion are presumably further
along the progressive course of beta-cell dysfunction
which characterizes the natural history of type 2 diabetes
[18]. Bonora et al. [19] when evaluating cross-sectional
associations of blood glucose two hours after breakfast,
lunch, and dinner, measured at home in 3,284 diabetic
subjects, found similarly that age and diabetes duration
were associated with greater excursions, and obesity with
lesser ones.
On the other hand, the larger associations with clinical
outcomes found in obese individuals suggest that the
clinical impact of glycemic and triglyceride excursions
may be greater for these individuals. This finding is con-
sistent with the previous finding of a greater association
of rapidly absorbed carbohydrate in the diet with circu-
lating levels of C-reactive protein [20].
Few previous studies have evaluated the impact of
postprandial blood glucose excursions on cardiovascular
outcomes. Cavalot et al. [8] followed 529 individuals
with diabetes for an average period of five years after a
single profile of glucose values pre- and post-meals, and
demonstrated that hyperglycemia, measured two hours
after lunch, but not pre-meal measures, was an inde-
pendent risk factor for cardiovascular events (third vs.
Table 3 Difference between glucose and triglycerides excursions in individuals with diabetes according to clinical and
laboratory characteristics (n = 898)
Glucose excursion
(mg/dL)
95% CI P Triglycerides excursion
(mg/dL)
95% CI P
Obesity (BMI≥ 30 kg/m2)
Yes 49.2 44.3; 54.2 0.26 27.8 23.7; 31.8 0.74
No 52.2 48.0; 56.4 26.9 23.4; 30.3
Abdominal obesity
Yes 48.8 44.8; 52.9 0.10 28.3 25.0; 31.7 0.31
No 54.3 49.2; 59.4 25.8 21.4; 29.8
A1c > 7%
Yes 75.9 71.5; 80.4 <0.001 27.5 23.5; 31.6 0.86
No 33.2 29.4; 37.0 27.1 23.6; 30.5
Oral hypoglycemic treatment (without insulin)
Yes 46.1 42.3; 49.8 <0.001 27.9 24.7; 31.1 0.17
No 75.5 68.8; 82.3 23.3 17.5; 29.1
Insulin use
Yes 96.7 88.9; 104.4 <0.001 21.2 14.3; 28.2 0.09
No 44.6 41.3; 48.0 27.9 24.9; 30.9
Postural hypotension
Yes 82.0 62.1; 101.8 0.001 29.8 13.1; 46.4 0.77
No 49.8 46.5; 53.0 27.3 24.6; 30.0
Any cardiovascular complication
Yes 63.7 55.9; 71.5 0.001 27.0 20.6; 33.4 0.94
No 48.4 45.0; 51.2 27.3 24.5; 30.2
Myocardial infarction
Yes 72.7 59.4; 86.0 0.001 29.9 19.1; 40.8 0.62
No 49.7 46.4; 52.9 27.1 24.4; 29.8
Angina
Yes 61.3 49.5; 73.0 0.07 27.6 17.9; 37.2 0.96
No 50.0 46.8; 53.4 27.3 24.6; 30.0
Heart failure
Yes 65.7 51.1; 80.2 0.04 28.6 16.8; 40.4 0.82
No 50.2 47.0; 53.5 27.2 24.5; 29.9
Coronary disease
Yes 63.5 54.4; 72.7 0.004 27.6 20.1; 35.2 0.91
No 49.2 45.9; 52.6 27.2 24.4; 30.0
Stroke
Yes 74.6 54.3; 94.9 0.02 23.9 7.0; 40.7 0.69
No 50.4 47.1; 53.6 27.3 24.7; 30.0
Raised blood pressure
Yes 51.9 48.3; 55.5 0.32 26.9 23.9; 29.9 0.73
No 50.3 41.2; 54.8 28.0 22.4; 33.7
Hypertriglyceridemia
Yes 50.6 45.9; 55.3 0.84 27.2 23.3; 31.1 0.98
No 51.3 46.9; 55.6 27.3 23.7; 30.8
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Table 3 Difference between glucose and triglycerides excursions in individuals with diabetes according to clinical and
laboratory characteristics (n = 898) (Continued)
Low HDL-C
Yes 49.0 43.2; 54.9 0.44 28.9 24.1; 33.6 0.43
No 51.8 48.0; 55.6 26.5 23.4; 29.7
ELSA-Brasil, 2008–2010.
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and 2.12, 95% CI 1.04 to 4.32 in men). In a later study,
the same authors [9] followed 505 of these individuals
with diabetes for about 14 years and assessed the rela-
tionship of postprandial glycemia with mortality.
Hyperglycemia two hours after lunch was identified as
an independent risk factor for cardiovascular mortality
(individuals with postprandial glucose ≥ 180 mg/dL
vs. <180 mg/dL, HR = 1.45, 95% CI: 1.06 to 1, 99) and
overall mortality (HR = 1.85, 95% CI: 1.31 to 2.61).
Clinical trials aimed at minimizing postmeal glucose
peaks have produced mixed findings in terms of the as-
sociation of greater excursions with cardiovascular out-
comes. Esposito et al. [21] randomized 175 patients to
repaglinide or gyburide and subsequently followed them
for 12 months, finding that post-prandial peaks were
smaller (148 vs. 180 mg/dL), C-reactive protein and IL-6
lower, and the frequency of carotid artery intimal-media
thickness regression greater (52% vs. 18%) in theTable 4 Adjusted† differences between glucose and triglyceri
Glucose excursion Model 1
mg/dL 95% CI
Race (white vs. non-white) 5.3 −0.5; 11
Sex (male vs. female) −5.2 −10.9; 0
Age (10 years) 8.4 4.9; 11.8
Glycated hemoglobin (%) 13.3 11.7; 14
Body mass index (5 kg/m2)
Duration of diabetes (5 years)
Other medication for diabetes (yes vs. no)
Insulin use (yes vs. no)
Triglyceride excursion Model 1
mg/dL 95% CI
Race (white vs.non-white) 3.3 −2.2; 8.8
Sex (male vs. female) 2.1 −3.3; 7.5
Age (10 years) −2.8 −6.1; 0.4
Glycated hemoglobin (%) 0.87 −0.8; 2.2
Body mass index (5 kg/m2)
Duration of diabetes (5 years)
Other medication for diabetes (yes vs. no)
Insulin use (yes vs. no)
ELSA-Brasil, 2008–2010.
†Through linear regression model for other variables shown in each model in the tarepaglinide group, despite similar levels of HbA1C. On the
other hand, lesser within day glucose variability was not
associated with a reduction in cardiovascular events in a
clinical trial investigating lispro (vs. NPH) insulin as a
strategy to diminish postprandial glucose peaks [22]. How-
ever, the lispro intervention in this trial proved ineffective
in significantly altering intraday variability, and the trial,
stopped early for futility, and was of a relatively short
duration.
Oxidative stress and inflammation have been suggested
as potential mediators that could link postprandial hyper-
glycemia, in part through endothelial dysfunction [23-25],
to diabetes complications [26-28] although the association
of greater peaks with oxidative stress remains to be clearly
established [29]. Individuals with diabetes tend to exhibit
high levels of adhesion molecule markers of endothelial
dysfunction – ICAM-1, VCAM-1 and E-selectin [30].
These markers, along with those of oxidative stress, in-
crease after a test meal composed of fats (65 grams),de excursions in individuals with diabetes (n = 898)
Model 2
p mg/dL 95% CI p
.1 0.07 7.6 1.9; 13.3 0.01
.5 0.07 −2.1 −7.8; 3.5 0.45
<0.001 6.1 2.5; 9.6 <0.001
.9 <0.001 10.7 9.1; 12.3 <0.001
−5.6 −8.4; −2.8 <0.001
4.5 2.6; 6.4 <0.001
9.4 −1.2; 20.1 0.08
44.4 31.7; 57.1 <0.001
Model 2
p mg/dL 95% CI p
0.24 3.7 −2.1; 9.6 0.21
0.45 3.0 −2.9; 8.7 0.33
0.09 −3.3 −7,0; 0.3 0.07
0.33 0.6 −1.1; 2.3 0.48
1.0 −1.9; 3.9 0.51
0.2 −1.8; 2.3 0.82
−1.3 −12.3; 9.8 0.82
−8.1 −21.3; 5.0 0.22
ble.
Table 5 Adjusted† associations of glucose and triglyceride excursions (of 25 mg/dL) with clinical outcomes (n = 898)
Glucose excursion Model Global Obese (n=375) Non-obese (n=523) Interaction‡
OR 95% CI p OR 95% CI p OR 95% CI p p
Any cardiovascular complication 1 1.15 (1.06-1.25) <0.01 1.19 (1.01-1.39) 0.04 1.15 (1.03-1.27) 0.01 0.86
2 1.06 (0.95-1.17) 0.32 1.12 (0.92-1.36) 0.26 1.03 (0.89-1.19) 0.94 0.35
Heart disease 1 1.13 (1.03-1.25) 0.01 1.22 (1.03-1.46) 0.02 1.10 (0.98-1.25) 0.11 0.38
2 1.04 (0.91-1.18) 0.57 1.20 (0.96-1.50) 0.12 0.96 (0.82-1.14) 0.65 0.11
Myocardial infarction 1 1.21 (1.06-1.38) <0.01 1.32 (1.03-1.68) 0.03 1.17 (1.00-1.36) 0.05 0.42
Angina 1 1.11 (0.99-1.25) 0.09 1.21 (0.99-1.48) 0.06 1.07 (0.92-1.25) 0.41 0.36
Stroke 1 1.23 (1.02-1.48) 0.03 1.08 (0.63-1.84) 0.78 1.25 (1.-1.47) 0.05 0.50
Heart failure 1 1.15 (1.00-1.33) 0.06 1.19 (0.93-1.52) 0.16 1.15 (0.95-1.38) 0.15 0.90
Triglyceride excursion Global Obese (n=375) Non-obese (n=523) Interaction‡
OR 95% CI p OR 95% CI p OR 95% CI p p
Any cardiovascular complication 1 1.00 (0.90-1.12) 0.94 1.11 (0.91-1.35) 0.32 0.93 (0.81-1.08) 0.34 0.15
2 1.01 (0.90-1.13) 0.87 1.15 (0.93-1.43) 0.20 0.91 (0.78-1.06) 0.21 0.06
Heart disease 1 1.02 (0.89-1.16) 0.80 1.23 (0.96-1.58) 0.10 0.91 (0.78-1.07) 0.24 0.04
2 1.02 (0.90-1.17) 0.72 1.25 (0.95-1.63) 0.11 0.91 (0.77-1.07) 0.24 0.04
Myocardial infarction 1 1.07 (0.87-1.32) 0.52 1.12 (0.79-1.59) 0.53 1.05 (0.80-1.36) 0.73 0.79
Angina 1 1.01 (0.85-1.19) 0.93 1.36 (1.01-1.83) 0.04 0.86 (0.72-1.02) 0.09 0.01
Stroke 1 0.96 (0.76-1.21) 0.75 0.89 (0.64-1.24) 0.49 0.98 (0.72-1.33) 0.92 0.76
Heart failure 1 1.03 (0.84-1.27) 0.76 1.09 (0.79-1.49) 0.60 0.97 (0.75-1.26) 0.84 0.56
ELSA-Brasil, 2008–2010.
†Through logistic regression, as follows:
Model 1: age.
Model 2: model 1 + sex, glycated hemoglobin, duration of diabetes, use of insulin.
‡Excursion versus obesity interaction.
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combination producing a greater effect than either of its
parts in isolation.
Other studies have found a relationship between post-
prandial triglycerides and the complications of diabetes
and/or risk factors for these complications. The trigly-
ceride excursion after consumption of a test meal
(729 kcal/m2; 65.2 grams of fat, 24.75 grams of carbohy-
drates) has been shown to be higher in individuals with
diabetes; and among those with diabetes, to take longer
to return to baseline in those who already have macro-
vascular complications [32]. Coutinho et al. [33] found
that, in addition to an increase in triglyceride levels, con-
sumption of a test meal rich in fat (682.6 kcal, 56.1
grams of fat, 34.4 grams of carbohydrates) was associ-
ated with an increase in blood leukocytes and a decrease
in HDL-cholesterol. Teno et al. [11], in turn, found an
association of postprandial triglyceride levels (following
a standardized 9 kcal/kg meal) with the carotid intima-
media thickness of patients with diabetes. Non-fasting
triglycerides have been shown to predict cardiovascular
events, especially in women [34]. We did not demonstrate
any relationship of triglycerides (fasting, post-meal or ex-
cursion) with cardiovascular comorbidities, perhaps be-
cause our postprandial measure was two hours followingmeal consumption, too early to detect the triglyceride
peak, which generally occurs four hours after consump-
tion [35].
The recommended daily energy intake for our study
participants (based on being sedentary with a median
weight, height, and age) was 2310 kcal for men and
1755 kcal for women [36]. Nutritional recommenda-
tions generally allocate 20% of total energy intake to
breakfast [37]. For our subjects, this would be 460 kcal
to men and 351 kcal to women, approximately equal to
the test meal used in our study – 454.8 kcal. This load,
compared to others found in the literature, is small, but
was adopted as it approximated what participants
would be possibly taking in early morning if not being
examined in our clinics, was easily standardized and
was available at all investigation centers. Two of the
test meal studies cited above used a load according to
the body surface area which ranged from 700 kcal/m2
[31] to 730 kcal/m2 [32], resulting in 1211 to 1263 kcal
load for a 1.73 m2 individual. As our participants me-
dian body surface area was 1.84 m2, this would translate
to 1288 kcal to 1343 kcal. Others determined the load
based on weight, and ranged from 9 kcal/kg [11] to
30 kcal/kg [38], equivalent to a 630 to 2100 kcal load
for a 70 kg individual. Still others, which, like ours,
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higher number of calories, ranging from 500 [33] to
1480 kcal [39].
The relatively low energy intake in our study may thus
have underestimated the true effect of usual postprandial
glycemia in these mostly obese patients, especially if
lunch and dinner meals are considered. Given that the
caloric and fat content of meals usually taken by the
overweight or obese are considerably greater than those
we studied, it is likely that usual changes in blood glu-
cose and triglycerides will be outside of the range we
studied.
Another possible explanation for the small size of asso-
ciations found with comorbidities was the source of satu-
rated fat in the test meal of our study – dairy products.
Higher consumption of saturated fats from dairy products,
as assessed by a food frequency questionnaire, has been
associated with lower risk of cardiovascular events (HR =
0.79, 95% CI: 0.68 to 0.92, for each increase of 5 grams/
day) while consumption of saturated fat from meat is asso-
ciated with an increased risk (HR = 1.26, 95% CI: 1.02-
1.54, for each increase of 5 grams/day) [40]. Further, indi-
viduals already with prevalent comorbidity may have
dampened their excursions through medication use, thus
minimizing the associations we found.
It is also important to consider that both fasting and
post-load glucose measures are extremely variable, not
only between individuals, but also over time in a given
individual [41]. As our study performed only a single
measurement of plasma glucose and triglycerides, it can-
not be expected to capture this biological variation, thus
also potentially decreasing the size of associations seen
[42,43].
In summary, a relatively small test meal, composed of
foods common to breakfast with rapidly absorbed carbo-
hydrate and saturated fat, produced variable postload ex-
cursions in a large sample of diabetic subjects, the
magnitude of the glycemic excursions being correlated
with factors suggesting insulin insufficiency. Though no
associations with the presence of diabetes complications
were found, small and at times statistically significant as-
sociations of greater excursions with comorbidity were
seen in those with obesity. These findings suggest that
postprandial excursions resulting from intake of rapidly
absorbed carbohydrate and saturated fat of this magni-
tude, though perhaps without impact on diabetes compli-
cations in the non-obese, may be of importance in obese
subjects with a lesser capacity for insulin secretion.
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